UK backs use of Merck cancer immu**therapy after price discount
 

UK backs use of Merck cancer immu**therapy after price discount
LONDON, Sept 7 (Reuters) - Britain's healthcare cost-effectiveness watchdog NICE on Monday recommended use of Merck's immu**therapy drug Keytruda, after the U.S. drugmaker promised to supply it to... http://feeds.feedburner.com/~ff/reut...?d=yIl2AUoC8zA [IMG]http://feeds.feedburner.com/~ff/reuters/governmentfilingsNews?i=NL**nRdmhFE:483xVp_TF0I:V_ sGLiPBpWU[/IMG] [IMG]http://feeds.feedburner.com/~ff/reuters/governmentfilingsNews?i=NL**nRdmhFE:483xVp_TF0I:F7 zBnMyn0Lo[/IMG]
[IMG]http://feeds.feedburner.com/~r/reuters/governmentfilingsNews/~4/NL**nRdmhFE[/IMG]